Loading
Latest filing published 26 Oct 2020 for CytoDyn Inc., €21k.
No signal scores available.
Not enough history yet: 1 closed purchase, at least 2 are needed.
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Arian Colachis appears in our data through filings on CytoDyn Inc. shares, published by SEC (Form 4). In total, 2 filings cover trades dated from 30 September 2020 to 23 October 2020.
Purchases make up the whole of the open-market record (1 purchase, €21k). Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Other entries cover 1 share grant.
Most recently, on 26 October 2020, the filings show an open-market purchase worth €21k in CytoDyn Inc. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 of 2 declarations